Processa Pharmaceuticals, Inc. Other Assets
Processa Pharmaceuticals, Inc. (PCSA) had Other Assets of $5.54 thousand as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Assets › Prepaid Expense and Other Assets
us-gaap:OtherAssets · last filed 2025-08-07
- 2025-06-30: Other Assets $5.54K.
- 2025-03-31: Other Assets $5.54K.
- 2024-12-31: Other Assets $5.54K.
- 2023-12-31: Other Assets $5.54K.
| Period end | Other Assets |
|---|---|
| 2025-06-30 | $5.54K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.54K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $5.54K 10-Q · filed 2025-08-07 |
| 2023-12-31 | $5.54K 10-K · filed 2025-03-20 |
| 2015-12-31 | $159.00 10-K · filed 2017-09-25 |
| 2015-09-30 | $175.52K 10-Q · filed 2015-12-01 |
| 2015-06-30 | $398.52K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $2.05M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.16M 10-K · filed 2017-06-19 |
| 2014-09-30 | $2.27M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.32M 10-Q · filed 2014-08-19 |
| 2014-03-31 | $2.43M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $2.42M 10-K · filed 2015-04-14 |
| 2013-09-30 | $2.53M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $2.53M 10-Q/A · filed 2013-09-06 |
| 2012-12-31 | $2.73M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |